Rawcliffe Adrian

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
30
Insider Sells Sum
$2.6M

Insider Activity of Rawcliffe Adrian

According to the SEC Form 4 filings, Rawcliffe Adrian, being in a position of

  1. Chief Executive Officer at Adaptimmune Therapeutics plc,
    оver the last 12 months, has bought 0 shares, and sold 90170 shares for $52,413,
    over all time since 2018-03-20, has bought 0 shares, and sold 1493558 shares for $2.6M.

The largest sale of all time was on 2018-03-20 and amounted to 1200000 shares of Adaptimmune Therapeutics plc for $2.05M.

Biography of Rawcliffe Adrian

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$52,4133100

Comparison of Insiders on Amount of Buys and Sells

2025-01-17SaleAdaptimmune Therapeutics plc
ADAP
Chief Executive Officer
30,601
0.0121%
$0.58$17,773-1.26%
2025-01-15SaleAdaptimmune Therapeutics plc
ADAP
Chief Executive Officer
29,096
0.0107%
$0.57$16,724-5.57%
2025-01-13SaleAdaptimmune Therapeutics plc
ADAP
Chief Executive Officer
30,473
0.0118%
$0.59$17,915-3.66%
2024-01-17SaleAdaptimmune Therapeutics plc
ADAP
Chief Executive Officer
30,080
0.0124%
$0.67$20,244+43.43%
2024-01-16SaleAdaptimmune Therapeutics plc
ADAP
Chief Executive Officer
9,304
0.0046%
$0.79$7,350+46.48%
2024-01-12SaleAdaptimmune Therapeutics plc
ADAP
Chief Executive Officer
17,257
0.0078%
$0.85$14,739+26.38%
2024-01-11SaleAdaptimmune Therapeutics plc
ADAP
Chief Executive Officer
11,945
0.005%
$0.84$9,994+18.2%
2023-09-01SaleAdaptimmune Therapeutics plc
ADAP
Chief Executive Officer
2,403
0.001%
$0.78$1,874+27.85%
2023-06-27SaleAdaptimmune Therapeutics plc
ADAP
Chief Executive Officer
2,333
0.0014%
$0.92$2,146-2.55%
2023-01-17SaleAdaptimmune Therapeutics plc
ADAP
Chief Executive Officer
10,057
0.0065%
$1.86$18,686-47.14%
2023-01-12SaleAdaptimmune Therapeutics plc
ADAP
Chief Executive Officer
18,763
0.0107%
$1.71$32,010-49.29%
2023-01-11SaleAdaptimmune Therapeutics plc
ADAP
Chief Executive Officer
13,042
0.0078%
$1.75$22,782-48.04%
2023-01-04SaleAdaptimmune Therapeutics plc
ADAP
Chief Executive Officer
5,073
0.0029%
$1.69$8,594-47.53%
2022-09-01SaleAdaptimmune Therapeutics plc
ADAP
Chief Executive Officer
2,536
0.0016%
$1.97$4,993-31.77%
2022-06-27SaleAdaptimmune Therapeutics plc
ADAP
Chief Executive Officer
2,562
0.0015%
$1.63$4,176-10%
2022-01-18SaleAdaptimmune Therapeutics plc
ADAP
Chief Executive Officer
11,096
0.0074%
$3.19$35,416-40.52%
2022-01-12SaleAdaptimmune Therapeutics plc
ADAP
Chief Executive Officer
3,046
0.002%
$3.54$10,795-46.49%
2022-01-11SaleAdaptimmune Therapeutics plc
ADAP
Chief Executive Officer
14,362
0.0091%
$3.56$51,081-48.88%
2022-01-04SaleAdaptimmune Therapeutics plc
ADAP
Chief Executive Officer
5,532
0.0037%
$4.06$22,483-52.08%
2021-09-01SaleAdaptimmune Therapeutics plc
ADAP
Chief Executive Officer
2,782
0.0018%
$5.20$14,452-53.27%
Total: 30
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.